## **Core Concept**
Noninvasive prenatal testing (NIPT) refers to a set of prenatal tests that analyze the DNA present in the maternal bloodstream to screen for certain genetic conditions in the fetus. This approach primarily focuses on detecting cell-free fetal DNA (cffDNA) that originates from the placenta. NIPT is used to assess the risk of various genetic disorders.

## **Why the Correct Answer is Right**
The correct answer, , involves the analysis of cell-free fetal DNA (cffDNA) present in the maternal circulation. This DNA is shed from the placental cells into the maternal bloodstream. By analyzing this cffDNA, NIPT can provide information on the presence of certain genetic abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13), with a high degree of accuracy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not accurately describe the basis of NIPT.
- **Option B:** This option is incorrect as it does not relate to the methodology or purpose of NIPT.
- **Option D:** This option is incorrect because it also does not accurately describe NIPT.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while NIPT is highly sensitive and specific for certain conditions, it is a screening test, not a diagnostic test. This means that a positive result requires further diagnostic testing, such as amniocentesis or chorionic villus sampling (CVS), to confirm the presence of a genetic disorder.

## **Correct Answer:** . Cell-free fetal DNA.